Hydrophobic Salts Markedly Diminish Viscosity of Concentrated Protein Solutions

被引:83
作者
Du, Wei [1 ,2 ]
Klibanov, Alexander M. [1 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
[2] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China
关键词
salts; bovine serum albumin; gamma-globulin; protein liquid formulations; pharmaceutical excipients; REVERSIBLE SELF-ASSOCIATION; MONOCLONAL-ANTIBODY THERAPY; FORMULATION; STABILITY;
D O I
10.1002/bit.22983
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Reducing viscosities of concentrated solutions of therapeutic proteins is important for their subcutaneous and intravenous delivery. Although inorganic salts and optimizing the pH were previously reported to dramatically lower the viscosity of a monoclonal antibody solution, herein we have determined these effects not to be general. Separately, we have found that hydrophobic ionic excipients, both anionic and cationic, substantially decrease the viscosity of concentrated (300-400 mg/mL) aqueous solutions of bovine serum albumin and gamma-globulin. The more hydrophobic the excipient, the greater its viscosity-lowering effect is. With cationic ones, the concomitant contribution of the counter-ion broadly follows the chaotropic order. The most potent excipients lower the viscosity over fourfold to levels far below the 50 cP threshold for subcutaneous injections. The observed viscosity reductions are rationalized in terms of three-dimensional transient protein networks formed in concentrated solutions due to hydrophobic and, to a lesser extent, ionic interactions. These reversible protein aggregates are responsible for strong resistance to flow in concentrated protein solutions and hence their high viscosity; hydrophobic ions apparently effectively compete for these interprotein interactions, thereby giving rise to less viscous solutions. Biotechnol. Bioeng. 2011; 108: 632-636. (C) 2010 Wiley Periodicals, Inc.
引用
收藏
页码:632 / 636
页数:5
相关论文
共 15 条
[1]   Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[2]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[3]   Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions [J].
Chari, Ravi ;
Jerath, Kavita ;
Badkar, Advait V. ;
Kalonia, Devendra S. .
PHARMACEUTICAL RESEARCH, 2009, 26 (12) :2607-2618
[4]   High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration [J].
Dani, Bhas ;
Platz, Robert ;
Tzannis, Stelios T. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (06) :1504-1517
[5]   Protein drug stability: A formulation challenge [J].
Frokjaer, S ;
Otzen, DE .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (04) :298-306
[6]   Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies [J].
Harris, RJ ;
Shire, SJ ;
Winter, C .
DRUG DEVELOPMENT RESEARCH, 2004, 61 (03) :137-154
[7]   Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity [J].
Kanai, Sonoko ;
Liu, Jun ;
Patapoff, Thomas W. ;
Shire, Steven J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (10) :4219-4227
[8]   Evidence for the Use of Intravenous Immunoglobulins-A Review of the Literature [J].
Kivity, Shaye ;
Katz, Uriel ;
Daniel, Natalie ;
Nussinovitch, Udi ;
Papageorgiou, Neophytos ;
Shoenfeld, Yehuda .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2010, 38 (2-3) :201-269
[9]   Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution [J].
Liu, J ;
Nguyen, MDH ;
Andya, JD ;
Shire, SJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (09) :1928-1940
[10]   The utility of monoclonal antibody therapy in renal transplantation [J].
Loertscher, R .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (03) :797-800